-
Mashup Score: 1
Taxpayers and charities helped develop Zolgensma. Then it debuted at a record price, ushering in a new class of wildly expensive drugs. Its story upends the widely held conception that high prices reflect huge industry investments in innovation.
Source: www.propublica.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Taxpayers and charities helped develop Zolgensma. Then it debuted at a record price, ushering in a new class of wildly expensive drugs. Its story upends the widely held conception that high prices reflect huge industry investments in innovation.
Source: www.propublica.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2795
Much attention has been paid to the young Silicon Valley engineers working for Musk’s Department of Government Efficiency, but the group has also hired high-powered legal talent.
Source: www.propublica.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4
Internal documents and former company executives reveal how Cigna doctors reject patients’ claims without opening their files. “We literally click and submit,” one former company doctor said.
Source: www.propublica.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0How Trump’s EPA Threatens Efforts to Clean Up Areas Affected Most by Dangerous Air Pollution - 13 day(s) ago
In just two weeks, Donald Trump has made drastic changes to the Environmental Protection Agency. Here’s how they could impact efforts to reform toxic hot spots across the U.S. and who will be left to safeguard these communities.
Source: www.propublica.orgCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 10“People Will Die”: The Trump Administration Said It Lifted Its Ban on Lifesaving Humanitarian Aid. That’s Not True. - 17 day(s) ago
Organizations that provide vital care for desperate and vulnerable people around the world have been forced to halt operations, turn away patients and lay off staff. “I’ve never seen anything that scares me as much as this,” one doctor said.
Source: www.propublica.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 10“People Will Die”: The Trump Administration Said It Lifted Its Ban on Lifesaving Humanitarian Aid. That’s Not True. - 18 day(s) ago
Organizations that provide vital care for desperate and vulnerable people around the world have been forced to halt operations, turn away patients and lay off staff. “I’ve never seen anything that scares me as much as this,” one doctor said.
Source: www.propublica.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 18The Second Trump White House Could Drastically Reshape Infectious Disease Research. Here’s What’s at Stake. - 1 month(s) ago
Donald Trump’s pick to lead the federal health agency has vowed to replace hundreds of staffers and shift research away from infectious diseases and vaccines. Such an overhaul could imperil the development of life-saving treatments, experts warn.
Source: www.propublica.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 18The Second Trump White House Could Drastically Reshape Infectious Disease Research. Here’s What’s at Stake. - 1 month(s) ago
Donald Trump’s pick to lead the federal health agency has vowed to replace hundreds of staffers and shift research away from infectious diseases and vaccines. Such an overhaul could imperil the development of life-saving treatments, experts warn.
Source: www.propublica.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 18The Second Trump White House Could Drastically Reshape Infectious Disease Research. Here’s What’s at Stake. - 1 month(s) ago
Donald Trump’s pick to lead the federal health agency has vowed to replace hundreds of staffers and shift research away from infectious diseases and vaccines. Such an overhaul could imperil the development of life-saving treatments, experts warn.
Source: www.propublica.orgCategories: General Medicine News, Infectious DiseaseTweet
"We found that taxpayers and private charities... subsidized much of the science that yielded Zolgensma, providing research grants and opening the door to federal tax credits and other benefits that sped its path to approval." via @propublica https://t.co/F2VG1UkSEJ